Cardiff Oncology, Inc. <CRDF.O>: William Blair cuts to market perform rating
CRDF•Related News
Lockheed Martin develops NetSense 5G AI system to detect drones
LMT•
Nexxen Q2 FY26 net income drops 58% to USD 3.64 million; revenue rises 11% to USD 100.5 million
NEXN•
Nexera unit Fort Technology agrees to buy 50.1% of Logia USA for US$125,000 in shares
NEXR•
Sound Point Meridian Capital Estimates NAV Per Share As Of July 31, 2026 At $9.56-$9.66
SPMC•
Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
IPSC•